STATINS SLOW PROSTATE GROWTH: RESULTS FROM THE REDUCTION BY DUTASTERIDE OF CANCER EVENTS (REDUCE) TRIAL

被引：0
|
作者：
Muller, Roberto
Gerber, Leah
Moreira, Daniel
Andriole, Gerald
Parsons, J. Kellogg
Fleshner, Neil
Freedland, Stephen
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1567
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1249
引用
收藏
页码：E505 / E505
页数：1
相关论文
共 50 条
  • [1] DOES INSULIN RESISTANCE CREATE A BIGGER PROSTATE? RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
    Daniels, James P.
    Mirocha, James
    Zheng, Renning
    Moreira, Daniel M.
    Freedland, Stephen J.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E78 - E78
  • [2] Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial
    Allott, Emma H.
    Csizmadi, Ilona
    Howard, Lauren E.
    Muller, Roberto L.
    Moreira, Daniel M.
    Andriole, Gerald L.
    Roehrborn, Claus G.
    Freedland, Stephen J.
    [J]. BJU INTERNATIONAL, 2020, 125 (02) : 226 - 233
  • [3] THE UTILITY OF PSA FOR DETECTION OF PROSTATE CANCER IN MEN TRLATED WITH DUTASTERIDE RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY
    Andriole, G. L.
    Bostwick, D.
    Brawley, O.
    Gomella, L.
    Marberger, M.
    Montorsi, F.
    Pettaway, C.
    Tammela, T.
    Teloken, C.
    Tindall, D.
    Wilson, T. H.
    Somerville, M.
    Fowler, I.
    Rittmaster, R. S.
    [J]. JOURNAL OF MENS HEALTH, 2009, 6 (03) : 269 - 269
  • [4] Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial
    Zheng, Renning
    Daniels, James P.
    Moreira, Daniel M.
    Eslamimehr, Shakiba
    Freedland, Alexis R.
    Guerrios-Rivera, Lourdes
    Fowke, Jay H.
    Freedland, Stephen J.
    [J]. CANCER, 2024,
  • [5] The influence of unscheduled biopsies on prostate cancer detection in the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial
    Andriole, G. L.
    Pettaway, C.
    Tindall, D. J.
    Rittmaster, R. S.
    Wilson, T. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Effect of baseline characteristics on prostate cancer rates and risk reduction in the Reduction by Dutasteride of prostate Cancer Events REDUCE) trial
    Andriole, G.
    Brawley, O.
    Gomella, L.
    Marberger, M.
    Montorsi, F.
    Pettaway, C.
    Teloken, C.
    Tammela, T.
    Tindall, D.
    Rittmaster, R.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 407 - 408
  • [7] THE INFLUENCE OF UNSCHEDULED BIOPSIES ON PROSTATE CANCER DETECTION IN THE REDUCE (REDUCTION OF DUTASTERIDE IN CANCER EVENTS) TRIAL
    Marberger, M.
    Montorsi, F.
    Bostwick, D.
    Fowler, I. L.
    Wilson, T. H.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 217 - 217
  • [8] DOES INSULIN RESISTANCE PREDICT AGGRESSIVE PROSTATE CANCER? RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER (REDUCE) TRIAL
    Zheng, Renning
    Daniels, James P.
    Moreira, Daniel
    Freedland, Stephen J.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E618 - E618
  • [9] EFFECT OF BASELINE PROSTATE CANCER RISK ON DUTASTERIDE EFFICACY IN THE REDUCE (REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS) STUDY
    Marberger, M.
    Pettaway, C.
    Tammela, T.
    Tindall, D. J.
    Teloken, C.
    Wilson, T. H.
    Castro, R.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 300 - 301
  • [10] INCIDENCE OF BIOPSY-DETECTABLE PROSTATE CANCER IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL: BLINDED 2-YEAR RESULTS
    Andriole, Gerald L.
    P-ettaway, Curtis A.
    Teloken, Claudio
    Fowler, Ivy L.
    Somerville, Matt C.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 800 - 800
12345